reviewEuropean Respiratory JournalNov 30, 2005BRONZE OA

Guidelines for the management of adult lower respiratory tract infections

MWMark WoodheadFBF. BlasiSES. EwigGHG. HuchonMLM. Leven

Manchester Royal Infirmary

PubMed
Indexed incrossrefpubmed

Abstract

No risk factors for P. aeruginosa (see table 12) Nonantipseudomonal cephalosporin III+macrolide # or Nonantipseudomonal cephalosporin III+(moxifloxacin or levofloxacin) Risk factors for P. aeruginosa (see table 12) Anti-pseudomonal cephalosporin " or Acylureidopenicillin/b-lactamase inhibitor or Carbapenem + ciprofloxacin P. aeruginosa: Pseudomonas aeruginosa. # : new macrolides preferred to erythromycin

Citation impact

892
total citations
FWCI
40.22
Percentile
100%
References
389
Citations per year

Authors

10

Topics & keywords

Keywords
  • Guideline
  • Medicine
  • Intensive care medicine
  • Respiratory tract infections
  • Pneumonia
  • Community-acquired pneumonia
  • Task force
  • Specialty
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.